Related Experiment Video
Updated: Apr 6, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Epidemiology of coeliac disease in children and adolescents with type 1 diabetes: a 13-year population-based study
Alessandro Fontanarosa1, Marica Iommi2, Federico Cesanelli3
1Center of Epidemiology, Biostatistics and Medical Information Technology, Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.
Aims:
To study the epidemiology of Coeliac Disease (CD) in the general paediatric population and among children with Type 1 Diabetes (T1D) in a population of Central Italy, and to assess the temporal trends of these two chronic conditions.
Methods:
A population-based longitudinal study on children aged < 15 was conducted using Healthcare Utilization Databases of the Marche Region, 2011-2023. Prevalent and incident cohorts of T1D and CD were identified using hospital discharges, drug prescriptions, and healthcare exemption databases. Prevalence ratios (PR), incidence rate ratios (IRR), temporal trends, and cumulative CD risk after T1D diagnosis were assessed with 95% confidence intervals (CI).
Results:
Overall 13-year period prevalences of T1D and CD were 1.65‰ and 5.28‰, respectively. CD prevalence among children with T1D was 97.7‰, 18-fold higher than in the general population (PR 18.6; 95%CI 14.3-24.0). CD incidence was 65 per 100,000 person-years in the general population and 2,410 per 100,000 person-years among children with newly diagnosed T1D (IRR 37.0; 95%CI 24.7-55.4). The six-year cumulative probability of developing CD in the T1D cohort was 10.3% (95%CI: 6.2%-14.3%).
Conclusions:
Children with T1D have a markedly increased risk of CD, particularly in the first years after diagnosis, supporting systematic CD screening in this high-risk population.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Psychoneuroimmunology: Diabetes and Cancer